Completed PHASE3 INTERVENTIONAL 3-arm NCT06285799

Safety and Effectiveness of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal Women

A Randomised, Double-blind Study to Determine the Safety and Efficacy of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal Women

Sponsor: Nemysis Ltd

Conditions Iron-deficiency

Interventions Carob Flour High Dose IHAT Low Dose IHAT

Updated 5 times since 2024 Last updated: Jun 3, 2025 Started: Mar 5, 2024 Primary completion: Feb 11, 2025 Completion: Feb 15, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Iron-deficiency, this trial is completed. The trial is conducted by Nemysis Ltd and has accumulated 5 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Jul 2025 — Present [monthly]

Completed PHASE3

Status: Recruiting → Completed
Sep 2024 — Jul 2025 [monthly]

Recruiting PHASE3
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE3
May 2024 — Jul 2024 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Mar 2024 — May 2024 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nemysis Ltd
RDC Clinical Pty Ltd

Data source: Nemysis Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brisbane, Australia